Mylan N.V. Stock Price and Value Analysis

Should you buy Mylan N.V. stock? (NasdaqGS:MYL). Let's see how it does in our automated value investing analysis system.

  • This company is very stable.
  • This company has amazingly consistent growth!
  • This stock looks overpriced.
  • This company is not making money.
  • This company pays no dividend.

Inside the MYL Numbers

MYL Price
(Mylan N.V. stock price per share)
PE Ratio versus Sector 1399% higher than other Healthcare stocks
PE Ratio versus Industry 14% lower than other Drug Manufacturers - Specialty & Generic stocks
Cash Yield 4.21%

Is Mylan N.V. Stock on Sale?

Based on our analysis, we believe that you should not buy Mylan N.V. right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy MYL Stock?

Does Mylan N.V. have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.